On this page
MLH3
mutL homolog 3
The MLH3 gene provides instructions for making a protein that is a crucial component of the DNA mismatch repair (MMR) pathway, essential for maintaining genomic integrity and preventing mutations. MLH3 is a gene central to the body's DNA repair machinery, specifically the mismatch repair system.
MLH3 is located on the long (q) arm of chromosome 14, at band 14q24.3. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 14 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The MLH3 gene, or mutL homolog 3, plays a significant role in the maintenance of genomic stability within human cells. It encodes a protein that is part of the DNA mismatch repair (MMR) system, a vital cellular process responsible for correcting errors that can arise during DNA replication [PMID:16979261]. These errors, if left uncorrected, can lead to mutations that contribute to various diseases, including cancer.
The MLH3 protein works in conjunction with other proteins to recognise and repair incorrectly paired bases or small insertions and deletions in the DNA sequence. Its function is particularly important in contexts where DNA is frequently replicating, as this is when the majority of these errors occur. Inherited alterations in the MLH3 gene can impair this repair mechanism, leading to an increased rate of spontaneous mutations throughout the genome. This elevated mutation rate is directly linked to an increased lifetime risk of developing certain types of cancer, categorising MLH3 as a cancer predisposition gene [PMID:24075133]. Understanding the MLH3 gene and its functional integrity is therefore crucial for assessing genetic susceptibility to these conditions.
What the gene does
The MLH3 gene provides instructions for synthesising the MLH3 protein, which is an integral component of the DNA mismatch repair (MMR) pathway. This pathway is a highly conserved biological system that serves as a quality control mechanism for DNA, correcting errors that occur during DNA replication and recombination [PMID:11590426]. Specifically, the MLH3 protein forms a heterodimer with the MLH1 protein, creating a complex known as MutLγ. This MutLγ complex is one of several MutL homologues involved in the MMR pathway.
The primary function of the MutLγ complex (MLH1-MLH3) is to act downstream of the initial mismatch recognition step, which is typically carried out by other protein complexes such as MutSα (MSH2-MSH6) or MutSβ (MSH2-MSH3). Once a mismatch or an insertion/deletion loop has been identified by a MutS complex, the MutLγ complex is recruited to the site. Its precise roles include coordinating with other proteins involved in DNA excision, resynthesis, and ligation. The MutLγ complex is thought to be involved in activating the exonuclease EXO1, which excises the incorrect DNA strand, and also in providing structural scaffolding for other repair proteins to bind and function effectively [PMID:16979261].
Beyond its core role in DNA mismatch repair, the MLH3 protein also participates in meiotic recombination. During meiosis, genetic material is exchanged between homologous chromosomes, a process vital for genetic diversity. The MLH1-MLH3 complex is involved in the formation of crossing-over events, ensuring proper segregation of chromosomes during cell division [PMID:12379373]. Therefore, MLH3's function extends beyond simply repairing somatic DNA errors; it also plays a critical role in germline stability and inheritance. Defects in MLH3 can lead to not only an increased cancer risk but potentially issues with fertility or offspring with chromosomal abnormalities, though its implications in meiosis are still an active area of research.
Video: Genetics 101
Chromosome location
The MLH3 gene is situated on the long arm of chromosome 14, specifically at position 14q24.3. This designation indicates that MLH3 is located on chromosome 14, within region q24.3, which is part of the q arm (the longer arm) of the chromosome. The precise genomic coordinates ensure that researchers and clinicians can consistently identify and study this gene. The MLH3 gene contains 22 exons, which are the coding regions of the gene that are ultimately translated into the protein. The appropriate splicing of these exons is essential for producing a functional MLH3 protein. Any genetic alterations that affect the location or structure of these exons could compromise the gene's ability to produce its vital DNA mismatch repair protein.
Protein structure
The MLH3 protein, comprising 1453 amino acids, is a component of the DNA mismatch repair machinery. Its structure is characterised by several important regions that facilitate its interactions and functions within the cell. The protein contains areas predicted to be intrinsically disordered, which often play roles in protein-protein interactions and signalling. Specifically, two such disordered regions have been identified: one spans amino acids 624-650, and another is located between amino acids 933-960. These Disordered Regions may allow for conformational flexibility, enabling the protein to interact with multiple partners or adopt different structures depending on the cellular context. While specific catalytic domains are often found in DNA repair proteins, the primary function of MLH3 as part of the MutLγ complex is thought to be primarily structural and regulatory, coordinating the activities of other repair proteins rather than directly carrying out enzymatic reactions. Further detailed structural characterisation continues to elucidate the precise roles of each domain within the MLH3 protein.
Key variants
Genetic variants within the MLH3 gene can significantly impact its function, leading to varying effects on an individual's health. These variants include single nucleotide changes, insertions, deletions, or larger rearrangements within the gene sequence. Each type of variant can affect how the MLH3 protein is produced, its stability, or its ability to interact with other proteins in the DNA mismatch repair pathway. Some variants may be benign, having no noticeable effect, while others are classified as pathogenic or likely pathogenic, meaning they are strongly associated with an increased risk of disease. The interpretation of MLH3 variants is complex, often requiring careful consideration of their predicted impact on protein function, their frequency in the general population, and segregation within affected families. Clinical genetic testing aims to identify such pathogenic variants to inform risk assessment and management strategies.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1267C>T | p.Gln423Ter | Pathogenic | ★★☆☆ | Colorectal cancer |
c.1323C>A | p.Tyr441Ter | Pathogenic | ★★☆☆ | Colorectal cancer, hereditary nonpolyposis, type 7 |
c.184_190del | p.Gly62fs | Pathogenic | ★★☆☆ | Colorectal cancer, hereditary nonpolyposis, type 7 |
c.214_215insTA | p.Arg72fs | Pathogenic | ★★☆☆ | Colorectal cancer, hereditary nonpolyposis, type 7 |
c.2983_2986del | p.Ile995fs | Pathogenic | ★★☆☆ | Colorectal cancer, hereditary nonpolyposis, type 7 |
c.3822_3823del | p.Leu1275fs | Pathogenic | ★★☆☆ | Colorectal cancer, hereditary nonpolyposis, type 7 |
c.3956del | p.Gly1319fs | Pathogenic/Likely pathogenic | ★★☆☆ | Colorectal cancer, hereditary nonpolyposis, type 7 |
c.581_582del | p.Ser194fs | Pathogenic | ★★☆☆ | Colorectal cancer, hereditary nonpolyposis, type 7 |
c.903del | p.Glu301fs | Pathogenic | ★★☆☆ | Colorectal cancer, hereditary nonpolyposis, type 7 |
c.979_980del | p.Leu327fs | Pathogenic | ★★☆☆ | Colorectal cancer, hereditary nonpolyposis, type 7 |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Inherited pathogenic variants in the MLH3 gene are primarily associated with an increased susceptibility to certain types of cancer due to impaired DNA mismatch repair. While MLH3's role is not as frequently implicated as some other MMR genes, it contributes to familial cancer syndromes. The gene's involvement in the mismatch repair pathway means that defects can lead to a somatic mutation accumulation, which is a hallmark of tumour development. Individuals carrying pathogenic MLH3 variants may have an elevated lifetime risk for various malignancies. Further research is ongoing to fully characterise the spectrum and penetrance of conditions associated with MLH3 variants.
No disease links recorded for this gene in our reference set.
Inheritance pattern
Conditions caused by pathogenic MLH3 variants typically follow autosomal dominant inheritance.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
UK clinical status
Diet & lifestyle considerations
Given the MLH3 gene's established role in DNA mismatch repair and its association with cancer risk, certain lifestyle considerations may be beneficial for general health, though these are not specific treatments or preventative measures for MLH3-related conditions. Maintaining a balanced diet rich in fruits, vegetables, and whole grains is generally recommended to support overall cellular health and reduce the risk of many chronic diseases. Research suggests that a diet high in processed foods and red meat may increase cancer risk, which is a general population observation [PMID:30127263].
Regular physical activity is also widely recognised for its health benefits, including supporting a healthy immune system and potentially reducing the risk of certain cancers. Limiting alcohol consumption and avoiding tobacco products are critical lifestyle choices, as both are strong risk factors for numerous cancer types. Additionally, maintaining a healthy body weight is associated with a lower risk of several cancers. While these lifestyle factors are important for everyone, individuals with a genetic predisposition due to genes like MLH3 may find it particularly pertinent to adopt such health-promoting habits. However, these suggestions are general health recommendations and do not specifically target MLH3 gene function or directly reverse the effects of pathogenic variants; they aim to promote overall well-being.
Supplement considerations
For individuals with MLH3 gene variants or any genetic predisposition to cancer, it is essential to approach dietary supplements with caution. There is currently no conclusive scientific evidence that specific supplements can prevent cancer or directly correct the functional deficiencies caused by MLH3 pathogenic variants. The effectiveness of supplements in mitigating genetic risks is largely unproven.
While some supplements, such as certain vitamins or antioxidants, are often marketed with claims about their cancer-fighting properties, these claims are not typically supported by robust clinical trial data, especially in the context of inherited genetic predispositions. In some cases, high doses of certain supplements can even have adverse effects or interact negatively with medications. Therefore, before considering any supplements, it is strongly advised to discuss this with a healthcare provider. A doctor or a registered dietitian can offer personalised advice, assess potential risks and benefits, and ensure that any supplement choices are safe and appropriate for individual health needs, particularly for those managing a genetic cancer risk.
Frequently asked questions
What is the primary function of the MLH3 gene?
The MLH3 gene provides instructions for making a protein that is a key component of the DNA mismatch repair (MMR) system. This system corrects errors that occur during DNA replication, helping to maintain the integrity of our genetic code.
How can MLH3 gene variants affect health?
Pathogenic variants in the MLH3 gene can impair the DNA mismatch repair system, leading to an accumulation of genetic errors. This increased mutation rate is associated with an elevated lifetime risk of developing certain types of cancer.
Is MLH3 associated with hereditary cancer syndromes?
Yes, MLH3 is considered a cancer predisposition gene. Inherited pathogenic variants can increase an individual's susceptibility to hereditary cancer syndromes, though its specific contributions are still an area of active research.
Where is the MLH3 gene located?
The MLH3 gene is located on chromosome 14, specifically at position 14q24.3. This precise location helps in genetic mapping and understanding its genomic context.
Can lifestyle changes reduce the risk associated with MLH3 variants?
While lifestyle changes cannot alter the MLH3 gene itself, adopting healthy habits such as a balanced diet, regular exercise, limiting alcohol, and avoiding tobacco can promote overall health and may reduce the general risk of many diseases, including some cancers.
Should I take supplements if I have an MLH3 variant?
There is no conclusive evidence that specific supplements can prevent cancer or correct the effects of MLH3 variants. Always consult with a healthcare professional before taking any supplements, as they can provide personalised advice and assess potential risks.